MarketPulse — Real-Time Financial News & Market Analysis

Elicio Therapeutics granted 30,300 stock options at $8.59 per share to a new employee on February 17, 2026, vesting over four years.

NVIDIA and RTI showcase real-time AI integration for medical devices via webinar March 3, 2026, combining Holoscan platform with Connext DDS middleware to streamline edge deployment.

Brightpick expands into auto parts with major NAPA deal, deploying 100+ robots across multiple distribution centers following successful pilot program.

Interact launches 2026 Winter Update with AI analytics, Workday integration, and Executive Assistant Agent to enhance employee experience and streamline HR operations.

La Rosa Holdings acquires remaining stake in Florida realty brokerage, consolidating operations. Company also pursues data center expansion in Osceola County.

MTL Cannabis shareholders overwhelmingly approve Canopy Growth acquisition with 99.97% support. Court approval expected February 23, 2026, with closing targeted before March 2026.

Organigram to acquire German cannabis firm Sanity Group for €227M in all-cash deal, expanding European operations with funding from existing reserves and British American Tobacco investment.

Amazon discontinued its Blue Jay warehouse robot after three months due to manufacturing complexity and costs, pivoting toward alternative automation systems like Flex Cell and Orbital.

Alphabet and Meta emerge as top growth picks due to dominant digital advertising positions and AI investments. Alphabet trades at 26.5x P/E; Meta at 21x with strong AI revenue growth.

Nvidia secures multi-year AI infrastructure contract with Meta, supplying Blackwell and future chips plus networking solutions. Stock rises 1.85% on announcement.

Pyxus International earns Leadership status from CDP assessment, securing A- ratings in climate change and forestry, B rating in water security. Recognition validates environmental stewardship efforts.

Auddia stock surges 70% on merger deal with Thramann Holdings. Combined entity will rebrand as McCarthy Finney, closing in Q2 2026.

Chicago Atlantic Real Estate Finance will report Q4 2025 earnings on March 12, 2026, with an investor call at 9:00 a.m. ET.

Immunocore will report FY2025 results and business updates on February 25, 2026, via teleconference. The biotech firm will discuss commercial progress for its approved KIMMTRAK treatment and pipeline advancement.

Alzheimer's therapeutics market projected to exceed $6B by 2026 driven by rising disease prevalence and increased pharma investment in disease-modifying treatments.

OGE Energy raises 2026 guidance to $2.38-$2.48 EPS, citing infrastructure investment gains and load growth. Company projects 5-7% annual EPS growth through 2028.

WEBUY Global launches AI-powered travel platform Altitude, generating $400K in initial bookings. The platform combines immersive technology with personalized recommendations targeting luxury travelers.

Agricultural lighting market to triple from $14.66B (2025) to $47.27B by 2035, driven by LED adoption in greenhouses and vertical farming for energy efficiency gains.

Harrow Health will release 2025 financial results March 2, 2026, reaffirming $270-$280 million revenue guidance and highlighting its expanding pharmaceutical portfolio.

EyePoint Pharmaceuticals appoints Michael Campbell as Chief Commercial Officer. The ophthalmology veteran brings 30+ years of experience to lead commercial strategy for DURAVYU ahead of 2026 clinical data.